Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
3(27%)
Results Posted
14%(1 trials)

Phase Distribution

Ph phase_1
1
9%
Ph not_applicable
10
91%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(7)

Detailed Status

Completed7
Active, not recruiting2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (9.1%)
N/A10 (90.9%)

Trials by Status

completed764%
not_yet_recruiting19%
recruiting19%
active_not_recruiting218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11